Naturally Occurring Protein Balances Immune Protection and Excessive Tissue Inflammation

A naturally occurring protein can help the immune system fight viral infections while also reducing the damaging inflammation that often accompanies them, a new study from McMaster University has found.

Published in The Journal of Clinical Investigation on Oct. 15, 2026, the study examined interferon lambda (IFN-λ), part of the body's natural antiviral defense system. Researchers found that the protein helps control viral infections, lowers levels of inflammatory molecules linked to tissue damage, and strengthens important immune responses.

Researchers wanted to determine whether IFN-λ does more than simply fight viruses. This question is important because treatments that boost antiviral immunity can also increase inflammation, which in some cases can worsen disease.

The study found that IFN-λ may help strike a better balance. Rather than simply acting as an antiviral defense, the protein appears to help regulate the immune response, enabling the body to mount an effective and controlled defense against infection.

While the findings are promising, researchers stress that more work is needed to determine whether the same immune mechanisms operate in people and how the findings might eventually be translated into future therapies.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Icosagen Develops Manufacturing-Ready CHO Cell Line for EPOK Therapeutics' Complex Tetravalent Antibody-Like Protein